Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Modified Simultaneous Spectrophotometric Method Development for the Estimation of Duloxetine and Methylcobalamin in Bulk, Tablet and Capsule Dosage Forms


Affiliations
1 E.G.S. Pillay College of Pharmacy, Nagapattinam, Tamilnadu, India
2 College of Pharmacy, Shaqra University, Dawadmi, Saudi Arabia
3 Universiti Kuala Lumpur, Royal College of Medicine Perak, Faculty of Pharmacy and Health Sciences, Ipoh, Perak, Malaysia
     

   Subscribe/Renew Journal


Duloxetine is chemically N – methyl-3-(1-naphthyloxy)-3-(thiophen-2-yl)-propan-1-amine, is a balanced and potent reuptake inhibitor of serotonin and norepinephrine. Methylcobalamin is chemically Methyl-5, 6-dimethyl benzimidazolylcobalamin, is one of the two coenzyme forms of vitamin B12 in the enzyme methionine synthase which functions to transfer methyl groups for the regeneration of methionine from homocysteine. The combination of these two drugs is used in relieving the complications of diabetic peripheral neuropathy. The aim of the current study is to develop a modified simultaneous spectrophotometric determination (Q-Absorbance ratio method) of duloxetine and methylcobalaminin bulk and pharmaceutical dosage form (tablet and capsule). Duloxetine has exhibited maximum absorbance at 288 nm and it transparent at 326 nm. The isobestic point was selected at 254 nm as both the drugs recorded maximum absorbance, also it was found wavelength difference is higher when compared to 278 nm. In replicate analysis (n=5) of the two drugs by the proposed UV method, the % label claim and % RSD of duloxetine and methylcobalamin were appreciably low for tablet and capsule formulation. The correlation between absorbance and concentration in terms of correlation coefficient (r) was found to be 0.9956 and 0.9979. The validation parameters observed proved that this method simple, sensitive, accurate and precise. Hence, the developed new method can be employed for the routine analysis of these two drugs in combined dosage forms.

Keywords

Duloxetine, Methylcobalamin, Modified Simultaneous Method, Diabetic Peripheral Neuropathy and Isobestic Point.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Snyder LR, Glajch JL and Kirkland JJ, Practical HPLC Method Development. John Wiley2nd. 1988.

  • Beckett AH and J. B. Stenlake JB. Practical Pharmaceutical Chemistr. CBS Publishers and Distributers. 2005.

  • Balyejjusa, SA Dome RO and Musoke D. Spectrophotometric determination of Sulphamethoxazole and Trimethoprim (Co-trimoxazole) in binary mixtures and in tablets. African Health Sciences. 2002; 2(2):56–62.

  • Ahmed MMJ and Uddin MN. A simple spectrophotometric method for the determination of cobalt in industrial, environmental, biological and soil samples using bis(salicylaldehyde)orthophenylenediamine. Chemosphere, 2007; 67: 2020-2027.

  • Erk N. Three new spectrophotometric methods applied to the simultaneous determination of hydrochlorothiazide and irbesartan. Pharmazie. 2003; 58, 543-548.

  • Erk N. Simultaneous determination of fosinopril andhydrochlorothiazide in pharmaceutical formulations by spectrophotometric methods. J. Pharm. Biomed. Anal. 2002; 27: 901-912.

  • J. B. Cashtledine, A. F. Fell, R. Modin and B. Sellberg., J. Pharm. Biomed. Anal, 1991, 9, 619-624.

  • Duloxetine Hydrochloride” http://wiki. medpedia. com/Clinical: Cymbalta_(Duloxetine_hydrochloride), January 2013.

  • Drug profile of Methylcobalamin through www. Wikipedia. com

  • Snyder LR, Kirkland JJ and Glaichy J. Practical HPLC Method Development. John Wiley. 1997.

  • Kamila MM, Mondal N and Ghosh LK. A validated UV spectrophotometric method for determination of duloxetine hydrochloride. Pharmazie. 2007; 62, 414-415.

  • Sengamalam R, Ravindran M, Manish Gunjan, Meena S. Analytical method development and dissolution profile of Duloxetine and Methylcobalamin by Vierodt’s Method. Journal of Pharmacy Research. 2011; 4(2): 449-451.

  • Beckett AH and Stenlake JB. Practical Pharmaceutical Chemistry. CBS Publishers and Distributers. 2005.

  • Ahuja S and Scypinski S. Handbook of Modern Pharmaceutical Analysis. Academic Press. 2001.


Abstract Views: 156

PDF Views: 0




  • Modified Simultaneous Spectrophotometric Method Development for the Estimation of Duloxetine and Methylcobalamin in Bulk, Tablet and Capsule Dosage Forms

Abstract Views: 156  |  PDF Views: 0

Authors

Sengamalam Radhakrishnan
E.G.S. Pillay College of Pharmacy, Nagapattinam, Tamilnadu, India
S. Meena
College of Pharmacy, Shaqra University, Dawadmi, Saudi Arabia
Ravindran Muthukumarasamy
Universiti Kuala Lumpur, Royal College of Medicine Perak, Faculty of Pharmacy and Health Sciences, Ipoh, Perak, Malaysia

Abstract


Duloxetine is chemically N – methyl-3-(1-naphthyloxy)-3-(thiophen-2-yl)-propan-1-amine, is a balanced and potent reuptake inhibitor of serotonin and norepinephrine. Methylcobalamin is chemically Methyl-5, 6-dimethyl benzimidazolylcobalamin, is one of the two coenzyme forms of vitamin B12 in the enzyme methionine synthase which functions to transfer methyl groups for the regeneration of methionine from homocysteine. The combination of these two drugs is used in relieving the complications of diabetic peripheral neuropathy. The aim of the current study is to develop a modified simultaneous spectrophotometric determination (Q-Absorbance ratio method) of duloxetine and methylcobalaminin bulk and pharmaceutical dosage form (tablet and capsule). Duloxetine has exhibited maximum absorbance at 288 nm and it transparent at 326 nm. The isobestic point was selected at 254 nm as both the drugs recorded maximum absorbance, also it was found wavelength difference is higher when compared to 278 nm. In replicate analysis (n=5) of the two drugs by the proposed UV method, the % label claim and % RSD of duloxetine and methylcobalamin were appreciably low for tablet and capsule formulation. The correlation between absorbance and concentration in terms of correlation coefficient (r) was found to be 0.9956 and 0.9979. The validation parameters observed proved that this method simple, sensitive, accurate and precise. Hence, the developed new method can be employed for the routine analysis of these two drugs in combined dosage forms.

Keywords


Duloxetine, Methylcobalamin, Modified Simultaneous Method, Diabetic Peripheral Neuropathy and Isobestic Point.

References